Dr. Andrew J Ruden, General Practice Medicare: Medicare Enrolled Practice Location: 29600 S Wixom Rd, Wixom, MI 48393 Phone: 248-926-8459 Fax: 248-926-1310 |
News Archive
Freedom Neuro BV, a medical device distributor for Stimwave Technologies Incorporated, today announced CE Mark approval for the world's first Percutaneous Injectable Anchor System.
Uninsured patients in publicly funded community health centers face significant obstacles accessing specialty services outside of these centers, a new study finds.
The Endocrine Society and Medscape announced today a new partnership that brings together the Society's expertise and Medscape's innovative, peer-to-peer digital platforms and award-winning content to provide clinicians with the latest guidance and most relevant insights on diagnosing and treating diabetes, obesity, osteoporosis, infertility, and other endocrine disorders.
Bristol-Myers Squibb Company and Oncolys BioPharma Inc., a privately held biotechnology company based in Japan, announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire exclusive worldwide rights to manufacture, develop and commercialize festinavir, a once-a-day, orally available nucleoside reverse transcriptase inhibitor (NRTI) in Phase II development for HIV.
A review of almost one million haematopoietic stem cell transplantation procedures has highlighted differences in the availability of the procedure and the use of autologous and allogeneic transplants across the world.
› Verified 6 days ago